CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea · Delayed Price · Currency is KRW 2,140.00
-115.00 (-5.10%)
At close: Apr 2, 2026
CG MedTech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6,508 | 59.69 | 1,629 | -18,540 | -4,970 |
Depreciation & Amortization | 2,264 | 1,692 | 1,853 | 2,201 | 2,162 |
Loss (Gain) From Sale of Assets | -173.89 | -148.27 | -261.96 | -165.77 | -23.41 |
Asset Writedown & Restructuring Costs | 173.18 | - | 463.9 | - | 3,944 |
Loss (Gain) From Sale of Investments | 1,421 | 258.52 | 340.46 | -672.25 | -191.93 |
Stock-Based Compensation | - | 75.42 | 59.62 | 9.54 | - |
Provision & Write-off of Bad Debts | 299.78 | 202.99 | -3,918 | 126.82 | -107.26 |
Other Operating Activities | -3,625 | -2,226 | -1,365 | 18,953 | 619.7 |
Change in Accounts Receivable | -1,349 | 1,412 | 1,042 | -796.73 | 328.9 |
Change in Inventory | -3,653 | 1,546 | 613.45 | 152.11 | -645.64 |
Change in Accounts Payable | -1,082 | 336.52 | 281.19 | -1,733 | 604.71 |
Change in Other Net Operating Assets | 1,830 | -1,698 | -3,216 | -4,900 | -483.38 |
Operating Cash Flow | 2,613 | 1,511 | -2,478 | -5,365 | 1,237 |
Operating Cash Flow Growth | 72.95% | - | - | - | -42.45% |
Capital Expenditures | -11,479 | -773.97 | -1,590 | -819.5 | -862.16 |
Sale of Property, Plant & Equipment | 203.03 | 333.04 | 340.24 | 295.59 | 506.17 |
Cash Acquisitions | -8,485 | -3,084 | - | - | -1,597 |
Sale (Purchase) of Intangibles | -461.07 | -36 | -55.16 | -4.89 | -368.2 |
Investment in Securities | 5,596 | -5,709 | 56,461 | -52,696 | -3,205 |
Other Investing Activities | -777.51 | 183.39 | 18.12 | 201.9 | 204.99 |
Investing Cash Flow | -15,302 | -8,950 | 55,025 | -52,255 | -4,651 |
Short-Term Debt Issued | - | 360 | 700 | 81.31 | 596.15 |
Long-Term Debt Issued | - | - | - | 70,100 | 10,948 |
Total Debt Issued | - | 360 | 700 | 70,181 | 11,544 |
Short-Term Debt Repaid | -1,363 | -399.8 | - | -11,087 | -788.88 |
Long-Term Debt Repaid | -2,372 | -856.34 | -63,258 | -15,387 | -334.29 |
Total Debt Repaid | -3,735 | -1,256 | -63,258 | -26,475 | -1,123 |
Net Debt Issued (Repaid) | -3,735 | -896.14 | -62,558 | 43,707 | 10,421 |
Issuance of Common Stock | - | 22,325 | - | 24,179 | - |
Other Financing Activities | - | -52.05 | -0 | 0 | -0 |
Financing Cash Flow | -3,735 | 21,377 | -62,558 | 67,886 | 10,421 |
Foreign Exchange Rate Adjustments | -67.7 | 352.88 | 160.63 | -102.77 | 238.55 |
Net Cash Flow | -16,491 | 14,290 | -9,851 | 10,163 | 7,245 |
Free Cash Flow | -8,866 | 736.7 | -4,068 | -6,184 | 375.08 |
Free Cash Flow Growth | - | - | - | - | -80.72% |
Free Cash Flow Margin | -18.77% | 2.13% | -11.63% | -15.02% | 0.99% |
Free Cash Flow Per Share | -85.84 | 12.34 | -51.58 | -92.95 | 8.43 |
Cash Interest Paid | 414.98 | 207.98 | 144.01 | 1,869 | 352.3 |
Cash Income Tax Paid | 120.32 | -6.7 | -12.78 | 305.71 | 40.48 |
Levered Free Cash Flow | -7,545 | 4,127 | -460.1 | -9,617 | 766.1 |
Unlevered Free Cash Flow | -7,435 | 4,243 | -125.17 | -5,668 | 1,575 |
Change in Working Capital | -4,253 | 1,596 | -1,279 | -7,277 | -195.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.